GLYBERA Logo (USPTO, 04/23/2010)
USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark GLYBERA was filed as Word and figurative mark on 04/23/2010 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 03/20/2012.
The current status of the mark is "CANCELLED - SECTION 8".
| Trademark form | Word and figurative mark |
| File reference | 85021985 |
| Register number | 4113673 |
| Application date | April 23, 2010 |
| Publication date | January 3, 2012 |
| Entry date | March 20, 2012 |
Trademark owner
MEIBERGDREEF 61
1105 BA AMSTERDAM
NL
1105 BA AMSTERDAM
NL
Trademark representatives
goods and services
5
Pharmaceutical preparations and substances for the treatment of metabolic disorders and disorders which are a result of one or more mutations within the lipoprotein lipase gene; gene therapy vectors; biological preparations for medical use; biological preparations for medical use, namely, metabolic disorders and disorders which are a result of one or more mutations within the lipoprotein lipase gene; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing; pharmaceutical preparations, namely, vaccines and prophylaxis products for use in nuclei acid-based therapy, gene therapy and cell therapy; gene and nucleic acid modulation for the treatment of metabolic disorders and disorders which are a result of one or more mutations within the lipoprotein lipase gene; gene therapy and prophylaxis products, namely, gene delivery and gene transfer for the treatment of metabolic disorders and disorders which are the result of one or more mutations within the lipoprotein lipase gene; all the aforementioned goods used exclusively in the treatment of metabolic disorders and disorders which are a result of one or more mutations within the lipoprotein lipase gene
44
Medical treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders through gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation
ID: 1385021985